Plexision developing cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders.
Location: United States
Total raised: $365K
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.07.2025 | - | $365K | Richard Ki... |
Mentions in press and media 9
| Date | Title | Description |
| 26.07.2025 | AI Drives New Era in Transplant Diagnostics | Plexision, a biotechnology leader, secured significant investment from the Richard King Mellon Foundation. This funding fuels the integration of artificial intelligence and machine learning into advanced blood tests. The goal is revolutiona... |
| 25.07.2025 | Plexision Receives $365K from Richard King Mellon Foundation | Plexision, a Pittsburgh, PA-based biotechnology company developing blood tests, received a $365K investment from the Richard King Mellon Foundation. The amount of the deal was not disclosed. The funds will be used to accelerate the integrat... |
| 24.07.2025 | Plexision Secures Investment to Accelerate AI in Transplant Diagnostics | What You Should Know: – Plexision, a biotechnology company, today announced a $365k investment from the Richard King Mellon Foundation. The funds will be used to accelerate the integration of artificial intelligence (AI) and machine learnin... |
| 17.10.2022 | Plexision offers the first rapid blood test panel to predict cytomegalovirus infection and transplant rejection | PITTSBURGH–(BUSINESS WIRE)–October 17, 2022– Plexision, a biotechnology company, is offering the first blood test panel capable of reporting the risk of cytomegalovirus infection and transplant rejection within six hours after samples arriv... |
| 14.10.2022 | Plexision launches personalized transplant diagnostic testing in India | PITTSBURGH–(BUSINESS WIRE)–October 14, 2022– Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India. This laboratory will offer a comprehensive ran... |
| 18.10.2021 | Plexision Receives Laboratory Accreditation by the College of American Pathologists | PITTSBURGH–(BUSINESS WIRE)–October 18, 2021– Plexision, a biotechnology company, which provides personalized diagnostic testing services for organ transplant patients and for infections that affect immunocompromised patients has received Ac... |
| 18.10.2021 | Plexision : Receives Laboratory Accreditation by the College of American Pathologists | Plexision, a biotechnology company, which provides personalized diagnostic testing services for organ transplant patients and for infections that affect immunocompromised patients has received Accreditation by the College of American pathol... |
| 19.10.2020 | Plexision Awarded Competitive Grant from the National Science Foundation to Develop its Novel COVID-19 Immunity Test | Small Business Innovation Research Program Provides Seed Funding for R&D PITTSBURGH–(BUSINESS WIRE)–October 19, 2020– Plexision, (www.plexision.com) a biotech company specializing in cell-based technologies, has been awarded a National ... |
| - | Plexision | “Plexision developing cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders.” |